Evidence map›Paper›PMID 41463206›Full record

ArticleCancers2025

Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [

Gustavo Costa, Elham Yousefzadeh-Nowshahr, Valentina Vasic, Baiqing Sun, Luca Nagel, Alexander Wurzer, Franz Schilling, Ambros Beer, Wolfgang Weber, Susanne Kossatz and 1 more

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gustavo CostaDepartment of Nuclear Medicine, Ulm University, 89081 Ulm, Germany.
Elham Yousefzadeh-NowshahrDepartment of Nuclear Medicine, Ulm University, 89081 Ulm, Germany.ORCID 0000-0001-8675-9306
Valentina VasicDepartment of Nuclear Medicine, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-5989-5609
Baiqing SunCentral Institute for Translational Cancer Research (TranslaTUM), Technical University Munich, 81675 Munich, Germany.
Luca NagelDepartment of Nuclear Medicine, TUM University Hospital, TUM School of Medicine and Health, Bavarian Cancer Research Center (BZKF), 81675 Munich, Germany.ORCID 0000-0002-5530-6264
Alexander WurzerDepartment of Nuclear Medicine, TUM University Hospital, TUM School of Medicine and Health, Bavarian Cancer Research Center (BZKF), 81675 Munich, Germany.
Franz SchillingDepartment of Nuclear Medicine, TUM University Hospital, TUM School of Medicine and Health, Bavarian Cancer Research Center (BZKF), 81675 Munich, Germany.ORCID 0000-0001-5239-4628
Ambros BeerDepartment of Nuclear Medicine, Ulm University, 89081 Ulm, Germany.ORCID 0000-0001-9042-7806
Wolfgang WeberDepartment of Nuclear Medicine, TUM University Hospital, TUM School of Medicine and Health, Bavarian Cancer Research Center (BZKF), 81675 Munich, Germany.
Susanne KossatzCentral Institute for Translational Cancer Research (TranslaTUM), Technical University Munich, 81675 Munich, Germany.ORCID 0000-0002-1908-1782
Gerhard GlattingDepartment of Nuclear Medicine, Ulm University, 89081 Ulm, Germany.ORCID 0000-0001-7916-1576

Funding

Deutsche Forschungsgemeinschaft 502536527, GL 236/15-1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

[177Lu]Lu-rhPSMA-10.1digital twindosimetryPBPK modellingtargeted radionuclide therapy

Identifiers

PMID41463206
PMCPMC12730921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.